RNA-1083 vaccine is noninferior and induces higher immune responses than recommended influenza and COVID-19 vaccines.

Moderna’s Chief People & Digital Officer, Tracey Franklin, has become the latest high-profile executive to reveal how agentic ...

More than 3,000 GPTs are reportedly in use at Moderna, which has partnered with OpenAI. Here's how they're using the technology.

Pick a new kitchen, furniture, carpets, textiles, wallpaper, floors, and doors. If what you’re looking for isn’t in the ...

Moderna will merge its technology and HR teams departments, thanks to their increasing reliance on AI and ongoing OpenAI ...

MM+M Women of Distinction honoree, announced Monday morning that she has joined Medtronic Diabetes as its chief marketing ...

In Mann mit zwei Kindern, Gerhard Richter painted his close friend Sigmar Polke as a young child on an outing with his family ...

The vaccine maker, which has partnered with OpenAI since 2023, is rethinking how it does workforce planning thanks to the ...

We recently published a list of Billionaire David E. Shaw’s 10 Small-Cap Stock Picks with Huge Upside Potential. In this ...

A combination messenger RNA vaccine against COVID-19 and seasonal influenza stacked up well against currently recommended vaccines in a phase 3 trial, according to findings published in JAMA.

ANSWER: The problem isn’t that your immune system isn’t working; it’s working a little too well for your comfort but very ...

A new vaccine developed by Moderna aims to protect against both flu and COVID-19 with just one shot. Early studies suggest ...